国际眼科杂志
國際眼科雜誌
국제안과잡지
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY
2014年
1期
132-134
,共3页
增生性糖尿病视网膜病变%玻璃体切割术%激光
增生性糖尿病視網膜病變%玻璃體切割術%激光
증생성당뇨병시망막병변%파리체절할술%격광
proliferative diabetic retinopathy%vitrectomy%laser
目的：探讨玻璃体切割术与激光治疗在增生性糖尿病视网膜病变（ proliferative diabetic retinopathy ，PDR）中的联合应用价值。<br> 方法：选取我院2009-03/2010-03收治的PDR患者89例116眼，随机将患者分为对照组（47例62眼）和研究组（42例54眼）。对照组患者采用玻璃体切割术治疗，研究组患者在对照组患者治疗基础上，联合眼内激光进行治疗。比较分析患者治疗前后最佳矫正视力变化情况， FFA检查结果以及治疗后并发症发生情况。<br> 结果：与治疗前相比，对照组和研究组治疗后最佳矫正视力＜0．1的患者比率明显减少，分别为40％和28％，最佳矫正视力0．5～1．0的比率明显提高，分别达到24％和41％，差别均具有统计学意义（ P＜0．05）。与对照组患者治疗后相比，研究组患者治疗后最佳矫正视力0．5～1．0的比率明显提高，黄斑水肿消退或部分消退比率明显提高，而黄斑水肿加重、视网膜渗漏以及玻璃体再次出血比率明显降低，差别均具有统计学意义（ P＜0．05）。<br> 结论：玻璃体切割术联合激光是治疗PDR的有效方案，对患者术后视力的提高和并发症的降低具有积极的促进作用。
目的：探討玻璃體切割術與激光治療在增生性糖尿病視網膜病變（ proliferative diabetic retinopathy ，PDR）中的聯閤應用價值。<br> 方法：選取我院2009-03/2010-03收治的PDR患者89例116眼，隨機將患者分為對照組（47例62眼）和研究組（42例54眼）。對照組患者採用玻璃體切割術治療，研究組患者在對照組患者治療基礎上，聯閤眼內激光進行治療。比較分析患者治療前後最佳矯正視力變化情況， FFA檢查結果以及治療後併髮癥髮生情況。<br> 結果：與治療前相比，對照組和研究組治療後最佳矯正視力＜0．1的患者比率明顯減少，分彆為40％和28％，最佳矯正視力0．5～1．0的比率明顯提高，分彆達到24％和41％，差彆均具有統計學意義（ P＜0．05）。與對照組患者治療後相比，研究組患者治療後最佳矯正視力0．5～1．0的比率明顯提高，黃斑水腫消退或部分消退比率明顯提高，而黃斑水腫加重、視網膜滲漏以及玻璃體再次齣血比率明顯降低，差彆均具有統計學意義（ P＜0．05）。<br> 結論：玻璃體切割術聯閤激光是治療PDR的有效方案，對患者術後視力的提高和併髮癥的降低具有積極的促進作用。
목적：탐토파리체절할술여격광치료재증생성당뇨병시망막병변（ proliferative diabetic retinopathy ，PDR）중적연합응용개치。<br> 방법：선취아원2009-03/2010-03수치적PDR환자89례116안，수궤장환자분위대조조（47례62안）화연구조（42례54안）。대조조환자채용파리체절할술치료，연구조환자재대조조환자치료기출상，연합안내격광진행치료。비교분석환자치료전후최가교정시력변화정황， FFA검사결과이급치료후병발증발생정황。<br> 결과：여치료전상비，대조조화연구조치료후최가교정시력＜0．1적환자비솔명현감소，분별위40％화28％，최가교정시력0．5～1．0적비솔명현제고，분별체도24％화41％，차별균구유통계학의의（ P＜0．05）。여대조조환자치료후상비，연구조환자치료후최가교정시력0．5～1．0적비솔명현제고，황반수종소퇴혹부분소퇴비솔명현제고，이황반수종가중、시망막삼루이급파리체재차출혈비솔명현강저，차별균구유통계학의의（ P＜0．05）。<br> 결론：파리체절할술연합격광시치료PDR적유효방안，대환자술후시력적제고화병발증적강저구유적겁적촉진작용。
AIM: To probe into the clinical application value of vitrectomy with laser in treatment of proliferative diabetic retinopathy. <br> METHODS: Totally 89 patients ( 116 eyes ) with proliferative diabetic retinopathy in our hospital were selected from March 2009 to March 2010.The patients were divided into control group (47 cases, 62 eyes) and study group (42 cases, 54 eyes) randomly.The patients in control group were treated with vitrectomy. The patients in study group were treated with vitrectomy combined with eye laser.The best-corrected visual acuity ( BCVA) and FFA results of the patients before and after treatment, and occurrence of complications after treatment of the patients in two groups were compared and analyzed. <br> RESULTS: After treatment, the proportion of patients with best-corrected visual acuity <0.1 was reduced significantly in both groups ( P<0.05), which were 40%and 28%, respectively. And the proportion of patients with a BCVA ranging from 0.5 to 1.0 was also improved significantly ( P<0.05 ), which reached 24% and 41%, respectively.Compared with control group, the patients in study group after treatment, the rate of BCVA ranging from 0.5 to 1.0 was improved significantly, so did the rates of comprehensive regression of macular edema and partial regression of macular edema.While the rates of macular edema aggravation, retinal leakage and recurrence of vitreous bleeding were reduced significantly, the differences above were statistically significant (P<0.05). <br> CONCLUSION: Vitrectomy combined with laser treatment is an effective method for patients with proliferative diabetic retinopathy. It has a positive promoting role in improving postoperative visual acuity and reducing the occurrence of complications.
